Literature DB >> 20820752

Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Andreas Schmidt1, Stefan Endres, Simon Rothenfusser.   

Abstract

Recognition of pathogenic microbes by the innate immune system is based on the principle of pathogen-associated molecular patterns (PAMPs). These are conserved molecular structures that are present in the pathogen but not in the host. Cells of the innate immune system or, in some cases, virtually all cells of our body express receptors that are able to specifically recognize PAMPs and trigger the appropriate responses including the production of cytokines. In the case of viruses, an interesting complication exists: Viruses use the host's cellular metabolism and building blocks to replicate. As a consequence, protein modifications, lipid or carbohydrate configurations restricted to viruses do not exist. Instead, parts of the innate immune system have evolved to detect viral nucleic acids mainly by virtue of their (non-physiological) localization and structure. Understanding the molecules involved in anti-viral defence and the patterns they recognize will allow harnessing them for therapeutic strategies targeting viral and autoimmune diseases and tumours. This review presents important recent advances in understanding intracellular recognition of nucleic acid patterns by the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820752     DOI: 10.1007/s00109-010-0672-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  50 in total

1.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

2.  Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses.

Authors:  Kiyohiro Takahasi; Mitsutoshi Yoneyama; Tatsuya Nishihori; Reiko Hirai; Hiroyuki Kumeta; Ryo Narita; Michael Gale; Fuyuhiko Inagaki; Takashi Fujita
Journal:  Mol Cell       Date:  2008-01-31       Impact factor: 17.970

3.  RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

Authors:  Yu-Hsin Chiu; John B Macmillan; Zhijian J Chen
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

4.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

5.  LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.

Authors:  Takashi Satoh; Hiroki Kato; Yutaro Kumagai; Mitsutoshi Yoneyama; Shintaro Sato; Kazufumi Matsushita; Tohru Tsujimura; Takashi Fujita; Shizuo Akira; Osamu Takeuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

6.  Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.

Authors:  Robert Besch; Hendrik Poeck; Tobias Hohenauer; Daniela Senft; Georg Häcker; Carola Berking; Veit Hornung; Stefan Endres; Thomas Ruzicka; Simon Rothenfusser; Gunther Hartmann
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

7.  Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus.

Authors:  Martin Schlee; Andreas Roth; Veit Hornung; Cristina Amparo Hagmann; Vera Wimmenauer; Winfried Barchet; Christoph Coch; Markus Janke; Aleksandra Mihailovic; Greg Wardle; Stefan Juranek; Hiroki Kato; Taro Kawai; Hendrik Poeck; Katherine A Fitzgerald; Osamu Takeuchi; Shizuo Akira; Thomas Tuschl; Eicke Latz; Janos Ludwig; Gunther Hartmann
Journal:  Immunity       Date:  2009-07-02       Impact factor: 31.745

8.  Activation of MDA5 requires higher-order RNA structures generated during virus infection.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon-Ping Tan; Jan Rehwinkel; Hiroki Kato; Osamu Takeuchi; Shizuo Akira; Michael Way; Giampietro Schiavo; Caetano Reis e Sousa
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

9.  Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response.

Authors:  Sébastien Plumet; Florence Herschke; Jean-Marie Bourhis; Hélène Valentin; Sonia Longhi; Denis Gerlier
Journal:  PLoS One       Date:  2007-03-14       Impact factor: 3.240

10.  The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA.

Authors:  Diana A Pippig; Johannes C Hellmuth; Sheng Cui; Axel Kirchhofer; Katja Lammens; Alfred Lammens; Andreas Schmidt; Simon Rothenfusser; Karl-Peter Hopfner
Journal:  Nucleic Acids Res       Date:  2009-02-10       Impact factor: 16.971

View more
  13 in total

1.  Paramyxovirus V proteins interact with the RNA Helicase LGP2 to inhibit RIG-I-dependent interferon induction.

Authors:  Kay Childs; Richard Randall; Stephen Goodbourn
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 2.  Activation of RIG-I-like receptor signal transduction.

Authors:  Annie M Bruns; Curt M Horvath
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-11-08       Impact factor: 8.250

3.  Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus.

Authors:  Franziska S Hoffmann; Andreas Schmidt; Meike Dittmann Chevillotte; Christian Wisskirchen; Johannes Hellmuth; Simone Willms; Rachel H Gilmore; Jürgen Glas; Matthias Folwaczny; Tobias Müller; Thomas Berg; Ulrich Spengler; Karen Fitzmaurice; Dermot Kelleher; Nicole Reisch; Charles M Rice; Stefan Endres; Simon Rothenfusser
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

4.  A Tyr residue in the reverse transcriptase domain can mimic the protein-priming Tyr residue in the terminal protein domain of a hepadnavirus P protein.

Authors:  Jürgen Beck; Michael Nassal
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

5.  VPg-primed RNA synthesis of norovirus RNA-dependent RNA polymerases by using a novel cell-based assay.

Authors:  Chennareddy V Subba-Reddy; Ian Goodfellow; C Cheng Kao
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

6.  Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.

Authors:  Cindy Chiang; Vladimir Beljanski; Kevin Yin; David Olagnier; Fethia Ben Yebdri; Courtney Steel; Marie-Line Goulet; Victor R DeFilippis; Daniel N Streblow; Elias K Haddad; Lydie Trautmann; Ted Ross; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

7.  Parallels Between the Antiviral State and the Irradiated State.

Authors:  Heather M McGee; Ariel E Marciscano; Allison M Campbell; Arta M Monjazeb; Susan M Kaech; John R Teijaro
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 13.506

8.  ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis.

Authors:  J Andrejeva; H Norsted; M Habjan; V Thiel; S Goodbourn; R E Randall
Journal:  J Gen Virol       Date:  2012-10-10       Impact factor: 3.891

9.  The goose genome sequence leads to insights into the evolution of waterfowl and susceptibility to fatty liver.

Authors:  Lizhi Lu; Yan Chen; Zhuo Wang; Xiaofeng Li; Weihu Chen; Zhengrong Tao; Junda Shen; Yong Tian; Deqian Wang; Guoqin Li; Li Chen; Fang Chen; Dongming Fang; Lili Yu; Yudong Sun; Yong Ma; Jinjun Li; Jun Wang
Journal:  Genome Biol       Date:  2015-05-06       Impact factor: 13.583

Review 10.  Tumor suppressor activity of RIG-I.

Authors:  Xian-Yang Li; He-Zhou Guo; Jiang Zhu
Journal:  Mol Cell Oncol       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.